200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 13392-69-3
CAS No: 13392-69-3 Catalog No: AG0038AV MDL No:MFCD06203224
Title | Journal |
---|---|
Biosynthesis of polyhydroxyalkanaotes by a novel facultatively anaerobic Vibrio sp. under marine conditions. | Marine biotechnology (New York, N.Y.) 20120601 |
Parahydrogen-induced polarization (PHIP) hyperpolarized MR receptor imaging in vivo: a pilot study of 13C imaging of atheroma in mice. | NMR in biomedicine 20111001 |
In situ detection of PHIP at 48 mT: demonstration using a centrally controlled polarizer. | Journal of the American Chemical Society 20110112 |
Fast volumetric spatial-spectral MR imaging of hyperpolarized 13C-labeled compounds using multiple echo 3D bSSFP. | Magnetic resonance imaging 20100501 |
Cardiovascular applications of hyperpolarized contrast media and metabolic tracers. | Experimental biology and medicine (Maywood, N.J.) 20091201 |
Influence of Honey on the Suppression of Human Low Density Lipoprotein (LDL) Peroxidation (In vitro). | Evidence-based complementary and alternative medicine : eCAM 20090301 |
Degradation and controlled release behavior of epsilon-caprolactone copolymers in biodegradable antifouling coatings. | Biomacromolecules 20060301 |
High-performance liquid chromatography method for the determination of mycophenolic acid and its acyl and phenol glucuronide metabolites in human plasma. | Therapeutic drug monitoring 20060201 |
Novel carboxylated N-glycans contain oligosaccharide-linked glutamic acid. | Biochemical and biophysical research communications 20050715 |
Effect of heat treatment on the antioxidant activity of extracts from citrus peels. | Journal of agricultural and food chemistry 20040602 |
Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: similarities and difference in the metabolism of pitavastatin in monkeys and humans. | Xenobiotica; the fate of foreign compounds in biological systems 20030701 |
A tertiary alcohol analog of gamma-hydroxybutyric acid as a specific gamma-hydroxybutyric acid receptor ligand. | The Journal of pharmacology and experimental therapeutics 20030501 |
© 2019 Angene International Limited. All rights Reserved.